Lakhwani S, Rosiñol L, Puig N, Pico-Picos M-A, Medina-González L, Martínez-López J, Paiva B, Cedena M-T, Oriol A, Ríos-Tamayo R, Blanchard M-J, Jarque I, Bargay J, Moraleda J-M, Carrillo-Cruz E, Sureda A, Krsnik I, González E, Casado LF, Martí JM, Encinas C, De Arriba F, Palomera L, Sampol A, González-Montes Y, Motlló C, De La Cruz J, Alonso R, Mateos M-V, Bladé J, Lahuerta J-J, San-Miguel J, Hernández M-T. Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection. Haematologica 2024;109(6):1909-1917; https://doi.org/10.3324/haematol.2023.284154.